Session Chair Profile
Ph.D., Vice President of Corporate and Business Development, Inivata
Dr. Beeler oversees Inivata’s business development activities globally. Spanning a 20 year career in pharmaceutical development and diagnostics, John has established partnerships with leading pharmaceutical companies including GSK, Novartis, Gilead, and others. He holds a Masters degree in biology from Villanova University and a Ph.D. in pharmacology from the University of South Carolina School of Medicine.
Session Synopsis: Liquid Biopsy continues to generate interest among scientists and physicians, being easier to use for early diagnosis or when access to tissue is difficult. Adoption of the technology is slow, and the concentration of measurable biomarkers can vary from sample to sample. This session will discuss ways of breaking through the barriers to adoption, and the potential value to be gained through liquid biopsies.